OrthoPediatrics
KIDS
21.92
-0.56
-2.48%
OrthoPediatrics
US · KIDS
#3642 by market cap
Listed 2017
21.92
-0.56
-2.48%
Live - 5344 symbols - heartbeat 70s ago
· 2026-10-08 10:02
After-hours
22.26
-0.98%
- Market cap
- 572.39M
- P/E (TTM)i
- -13.05
- P/Bi
- 1.67
- EPSi
- -1.69
- Div yieldi
- 0.00%
- 52W posi
- 61%
Reader sentiment
Are you bullish or bearish on KIDS?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 2 in the most recent period (2026/Q3).
- Total institutional ownership fell 5.2 percentage points.
Institutional ownership
- Held by institutions
- 90.25% -5.25pp
- Institutions
- 151 -2
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund41.02%
VC/PE Fund24.38%
Hedge Fund19.56%
Individual/Insider6.45%
Public Company3.15%
Private Company1.17%
Insurance Company0.68%
Sovereign Wealth Fund0.24%
Other3.30%
Top holders as of 2026-09-10
Squadron Capital, LLC
23.75% · 6.20M sh
Brown Advisory Incorporated
6.43% · 1.68M sh
BlackRock
4.87% · 1.27M sh
Braidwell LP
4.21% · 1.10M sh
Granahan Investment Management, LLC
4.16% · 1.09M sh
Vanguard Capital Management, LLC
3.34% · 872.90K sh
Millennium Management LLC
3.13% · 816.83K sh
Wellington Management Group
3.04% · 794.31K sh
Soleus Capital Management, L.P.
2.80% · 732.14K sh
Morgan Stanley
2.64% · 688.60K sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 31 buys · 18 sells
| Name | Role | Stake |
|---|---|---|
| Squadron Capital, LLC | -- | 23.75% |
| David Bailey | Chief Executive Officer | 1.60% |
| Fred Hite | CFO, Principal Financial & Accounting Officer, COO and Director | 1.06% |
| Mark Throdahl | Executive Chairperson | 0.77% |
| Joseph Hauser | President of Trauma & Deformity Correction | 0.75% |
| Gregory Odle | President of Scoliosis | 0.72% |
| Daniel Gerritzen | Executive VP of Legal & General Counsel | 0.56% |
| David Pelizzon | Director | 0.17% |
| Harald Ruf | Director | 0.16% |
| Bryan Hughes | Independent Director | 0.13% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-09 | Squadron Capital, LLC | -- | Open Market Disposition | -302,369 | $21.01 |
| 2026-09-01 | Squadron Capital, LLC | -- | Open Market Disposition | -22,500 | $23.35 |
| 2026-08-31 | Squadron Capital, LLC | -- | Open Market Disposition | -336,831 | $23.04–23.10 |
| 2026-08-25 | Squadron Capital, LLC | -- | Open Market Disposition | -38,300 | $24.28–25.75 |
| 2026-06-08 | Mark Throdahl | Executive Chairperson | Other Acquisition | +11,436 | -- |
| 2026-06-08 | Samuel Riccitelli | Independent Director | Other Acquisition | +11,436 | -- |
| 2026-06-08 | David Bailey | Chief Executive Officer | Other Acquisition | +119,140 | -- |
| 2026-06-08 | David Pelizzon | Director | Other Acquisition | +11,436 | -- |
| 2026-06-08 | Bryan Hughes | Independent Director | Other Acquisition | +11,436 | -- |
| 2026-06-08 | Harald Ruf | Director | Other Acquisition | +11,436 | -- |
| 2026-06-08 | Marie Infante | Independent Director | Other Acquisition | +11,436 | -- |
| 2026-06-08 | Jimmy McDonald | Independent Director | Other Acquisition | +11,436 | -- |
| 2026-06-08 | George S. Dyer | Independent Director | Other Acquisition | +11,436 | -- |
| 2026-06-08 | Kelly Fischer | Director | Other Acquisition | +11,436 | -- |
| 2026-05-12 | Daniel Gerritzen | Executive VP of Legal & General Counsel | Other Disposition | -2,479 | -- |
| 2026-03-15 | Fred Hite | CFO, Principal Financial & Accounting Officer, COO and Director | Open Market Disposition | -12,993 | $17.25 |
| 2026-03-15 | David Bailey | Chief Executive Officer | Open Market Disposition | -19,535 | $17.25 |
| 2026-03-15 | Gregory Odle | President of Scoliosis | Open Market Disposition | -8,433 | $17.25 |
| 2026-03-15 | Daniel Gerritzen | Executive VP of Legal & General Counsel | Open Market Disposition | -8,614 | $17.25 |
| 2026-03-15 | Joseph Hauser | President of Trauma & Deformity Correction | Open Market Disposition | -8,596 | $17.25 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 10:02:57 · For reference only, not investment advice and not tailored to your situation.